This content is from: Transfer Pricing

Celltrion fine shows tax authority’s ambition to tackle violation of TP standards

The South Korean Financial Services Commission’s KRW 15.4 billion ($12.6 million) fine to global pharmaceutical company Celltrion is a warning to others to comply with accounting standards and transfer pricing rules.

To access our market-driven intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an ITR subscriber? Log in here

Instant access to all of our content. Membership Options | 30 Day Trial